DE3561321D1 - Preparation and use of new solvates of beclomethasone 17,21-diproprionate - Google Patents

Preparation and use of new solvates of beclomethasone 17,21-diproprionate

Info

Publication number
DE3561321D1
DE3561321D1 DE8585305303T DE3561321T DE3561321D1 DE 3561321 D1 DE3561321 D1 DE 3561321D1 DE 8585305303 T DE8585305303 T DE 8585305303T DE 3561321 T DE3561321 T DE 3561321T DE 3561321 D1 DE3561321 D1 DE 3561321D1
Authority
DE
Germany
Prior art keywords
diproprionate
beclomethasone
preparation
new solvates
solvates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585305303T
Other languages
English (en)
Inventor
Philip Ronald Rua Dos Gir Page
William Heggie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hovione Inter AG
Original Assignee
Hovione Inter AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PT7897284A external-priority patent/PT78972A/pt
Priority claimed from PT8079685A external-priority patent/PT80796B/pt
Application filed by Hovione Inter AG filed Critical Hovione Inter AG
Application granted granted Critical
Publication of DE3561321D1 publication Critical patent/DE3561321D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glass Compositions (AREA)
  • Saccharide Compounds (AREA)
DE8585305303T 1984-07-25 1985-07-25 Preparation and use of new solvates of beclomethasone 17,21-diproprionate Expired DE3561321D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT7897284A PT78972A (en) 1984-07-25 1984-07-25 Preparation process of a 17,21-dipropionate beclomethasona di-isopropylic ether solution and its utilization
PT8079685A PT80796B (pt) 1985-07-11 1985-07-11 Processo para a preparacao de solvatos etoericos de beclometasona 17,21-dipropionato e utilizacao dos mesmos

Publications (1)

Publication Number Publication Date
DE3561321D1 true DE3561321D1 (en) 1988-02-11

Family

ID=26653439

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585305303T Expired DE3561321D1 (en) 1984-07-25 1985-07-25 Preparation and use of new solvates of beclomethasone 17,21-diproprionate

Country Status (12)

Country Link
US (1) US4913892A (de)
EP (1) EP0172672B1 (de)
KR (1) KR880001237B1 (de)
AU (1) AU566318B2 (de)
CA (1) CA1274503A (de)
DE (1) DE3561321D1 (de)
DK (1) DK336485A (de)
HK (1) HK58789A (de)
IE (1) IE59086B1 (de)
IL (1) IL75903A (de)
NO (1) NO163899C (de)
NZ (1) NZ212877A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
MX9304585A (es) 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
CN1245982C (zh) * 1996-05-09 2006-03-22 阿姆瑞德手术有限公司 哮喘和气道疾病的治疗
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
AU2008214205B2 (en) 2007-02-11 2014-04-24 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
EP0039369B1 (de) * 1980-05-02 1983-06-15 Schering Corporation Beclomethason-ester-solvate, Verfahren zu ihrer Herstellung und Herstellung einer Formulierung
GB2107715B (en) * 1981-10-19 1985-11-13 Glaxo Group Ltd Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it

Also Published As

Publication number Publication date
NO163899B (no) 1990-04-30
NO163899C (no) 1990-08-08
IL75903A0 (en) 1985-12-31
DK336485D0 (da) 1985-07-24
DK336485A (da) 1986-01-26
EP0172672B1 (de) 1988-01-07
IL75903A (en) 1989-10-31
EP0172672A1 (de) 1986-02-26
KR860001122A (ko) 1986-02-22
US4913892A (en) 1990-04-03
CA1274503A (en) 1990-09-25
AU566318B2 (en) 1987-10-15
KR880001237B1 (ko) 1988-07-12
NZ212877A (en) 1988-03-30
AU4530585A (en) 1986-01-30
HK58789A (en) 1989-07-28
IE59086B1 (en) 1994-01-12
NO852948L (no) 1986-01-27

Similar Documents

Publication Publication Date Title
GB2159524B (en) Preparation of graft copolymer and paint use thereof
PH22672A (en) Imidazolylmethyltetrahydrocarbazolone derivatives, composition and method of use thereof
IL61508A (en) Preparation of 4'-epidaunorubicin and 3',4'-diepidaunorubicin and intermediates used therein
EP0164018A3 (en) Chromogenic 4,4-diaryl-dihydroquinazolones, their preparation and use
DE3561321D1 (en) Preparation and use of new solvates of beclomethasone 17,21-diproprionate
EP0166221A3 (en) Sunscreen composition and method of use
EP0201537A4 (de) Neue verwendung von anti-nausea- und antiemetischen pharmazeutischen mitteln.
PH23498A (en) 3-carbonyl-1-aminoalkyl-1h-indoles,composition and use thereof
GB2159817B (en) Preparation of amidohydroxycephams, novel aminoacyloxycephams and derivatives thereof
DE3562486D1 (en) Arginyl-3-carboxy-4-hydroxyanilide and their use
AU576717B2 (en) N6 - bicycloadenosines and methods of use
AU581445B2 (en) N-arylsulfonyl-N'-triazinylureas and N-arylsulfonyl-N'- pyrimidinylureas
GB2169508B (en) Ophthalmic compositions and use
DE3563624D1 (en) Novel substituted trifluorooxetane and preparation thereof
DE3362345D1 (en) Mixtures of specific 1,2-cycloaliphatic diepoxydes, and use thereof
GB2123421B (en) 2,6,6-trimethyl-cyclohex-3-en-1-one and preparation of b-damascenone therefrom
NZ213523A (en) Preparation of aromatic 1,4-oxazepinones and thiones
PH22247A (en) Diazepinoindole, pharmaceutical composition and method of use thereof
ZA86659B (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
IL74022A (en) Preparation of terpinen-4-ol and 1(7)-terpinen-4-ol
ZA855620B (en) Preparation and use of solvates of beclomethasone 17,21-dipropionate
DE3563049D1 (en) Chromogenic 4,4-diaryldihydrochinazolones, their preparation and use
ZA854139B (en) New use of dihydroergotamine
JPS6466148A (en) Manufacture of 1,5-diaminoheptanol-6, manufacture and use
DE3565101D1 (en) Ethynylphenoxy and ethynylthiophenoxy derivatives of diphenylhexafluoropropane

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee